R&D

News

AstraZeneca joins Tempus, Pathos in cancer AI project

AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology.

R&D

Shifting paradigms of clinical trial design accelerate CNS R...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed.

News

Roche joins the pharma firms planning big US investments

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.

News

Novartis radioligand therapy (RLT) manufacturing facility

Novartis plans $23bn manufacturing, R&D spend in US

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.

News

FDA plans to phase out animal testing for antibodies

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

News

CRUK scientists find new tool to test lung cancer therapies

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

AstraZeneca joins Tempus, Pathos in cancer AI project

Shifting paradigms of clinical trial design accelerate CNS R...

Roche joins the pharma firms planning big US investments

Novartis plans $23bn manufacturing, R&D spend in US

FDA plans to phase out animal testing for antibodies

CRUK scientists find new tool to test lung cancer therapies

Novo Nordisk fight with KBP Bio will go to arbitration

Discover a new era of healthcare panel engagement: Grounded ...

R&D

Editor's Picks